Association between End-Stage Renal Disease and Major Adverse Limb Events after Peripheral Vascular Intervention

Abstract

PurposeTo examine the effect of end-stage renal disease (ESRD) on the likelihood of major adverse limb events (MALEs) in patients with Rutherford Category 4–6 critical limb ischemia (CLI) who underwent percutaneous vascular intervention (PVI). Materials and MethodsTwo contemporaneous cohorts of patients who underwent PVI for symptomatic CLI from 2012 to 2022, differing in ESRD status, were matched using propensity score methods. This database identified 628 patients who underwent 1,297 lower extremity revascularization procedures; propensity score matching yielded 147 patients (180 limbs, 90 limbs in each group). Kaplan-Meier and Cox proportional hazard analyses were used to assess the effect of ESRD status on MALEs, stratified into major amputation (further stratified into above-knee amputation and below-knee amputation [BKA]) and reintervention (PVI or bypass). ResultsAfter PVI, 31.3% of patients in the matched cohorts experienced a MALE (45.7% ESRD vs 18.2% non-ESRD), and 15.6% experienced a major amputation (27.1% ESRD vs 5.2% non-ESRD). Cox proportional hazards analysis revealed that ESRD was an independent predictor of MALE (hazard ratio [HR], 3.15; 95% CI, 1.58–6.29; P = .001), major amputation (HR, 7.00; 95% CI, 2.06–23.79; P = .002), and BKA (HR, 7.56; 95% CI, 1.71–33.50; P = .008). ConclusionsESRD is strongly predictive of MALE and major amputation risk, specifically BKA, in patients undergoing PVI for Rutherford Category 4–6 CLI. These patients warrant closer follow-up, and new methods may become necessary to predict and further reduce their amputation risk.